|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 413/14 | (2006.01) |
| A61K 31/5377 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3057965 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14854037.0 |
| Date of filing the European patent application | 2014-10-17 | |
| (97) | Date of publication of the European application | 2016-08-24 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-02 |
| (46) | Date of publication of the claims translation | 2019-03-12 |
| (86) | Number | PCT/CA2014/051001 |
| Date | 2014-10-17 |
| (87) | Number | WO 2015/054793 |
| Date | 2015-04-23 |
| (30) | Number | Date | Country code |
| 201361892564 P | 2013-10-18 | US |
| (72) |
SAMPSON, Peter Brent, CA
FEHER, Miklos, US
PAULS, Heinz W., CA
|
| (73) |
University Health Network,
190 Elizabeth Street R. Fraser Elliott Building - Room 1S-417, Toronto, Ontario M5G 2C4,
CA
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | PLK-4 inhibitoriaus druska ir jos kristalinės formos |
| SALT AND CRYSTAL FORMS OF PLK-4 INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2024-10-01 | 11 | 289.00 EUR |
| 2025-10-17 |